col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


46 Results       Page 1

 [1] 
Springer-Verlag: Pharmacological Reports
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―18 Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, Mahdieh Abbasalizad Farhangi, Mohammad Bagherniya, Gholamreza Askari, et al. (+3)
2 [GO] 2023―Sep―01 Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study Juan Vicente-Valor, Carmen Rodríguez-González, María Ferris-Villanueva, Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Daniel Gómez-Costas, et al. (+6)
3 [GO] 2023―Aug―16 Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study Marwa O. El-Derany, Diana M. F. Hanna, John Youshia, Enas Elmowafy, Mohamed A. Farag, Samar S. Azab
4 [GO] 2023―Jun―24 Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments Raj Singh, Parth Malik, Mukesh Kumar, Raman Kumar, Md. Shamshir Alam, Tapan Kumar Mukherjee
5 [GO] 2023―Apr―05 Hospital antibiotic consumption-an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study Małgorzata Siewierska, Mateusz Gajda, Aleksandra Opalska, Michał Brudło, Paweł Krzyściak, Barbara Gryglewska, et al. (+2)
6 [GO] 2023―Feb―27 Nasal sprays for treating COVID-19: a scientific note Vivek P. Chavda, Kajal P. Baviskar, Dixa A. Vaghela, Shilpa S. Raut, Anjali P. Bedse
7 [GO] 2022―Dec―04 Platelets in COVID-19 disease: friend, foe, or both? Marta Smęda, Ebrahim Hosseinzadeh Maleki, Agnieszka Pełesz, Stefan Chłopicki
8 [GO] 2022―Nov―18 Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery Raahilah Zahir Essa, Yuan-seng Wu, Kalaivani Batumalaie, Mahendran Sekar, Chit-laa Poh
9 [GO] 2022―Nov―14 Health-related quality of life in survivors of severe COVID-19 infection Gabriele d’Ettorre, Paolo Vassalini, Vincenzo Coppolelli, Elio Gentilini Cacciola, Letizia Sanitinelli, Luca Maddaloni, et al. (+4)
10 [GO] 2022―Nov―07 Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials Subodh Kumar, Dibyajyoti Saikia, Mangesh Bankar, Manoj Kumar Saurabh, Harminder Singh, Sheshadri Reddy Varikasuvu, Vikas Maharshi
11 [GO] 2022―Oct―10 Recent review of COVID-19 management: diagnosis, treatment and vaccination Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma, Zhe-Sheng Chen
12 [GO] 2022―Oct―03 Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance Robert Flisiak, Dorota Zarębska-Michaluk, Magdalena Rogalska, Justyna Anna Kryńska, Justyna Kowalska, Ewa Dutkiewicz, et al. (+7)
13 [GO] 2022―Sep―30 Neurological consequences of COVID-19 Waldemar Brola, Maciej Wilski
14 [GO] 2022―Sep―27 Short-chain fatty acids-microbiota crosstalk in the coronavirus disease (COVID-19) Jakub Włodarczyk, Bartłomiej Czerwiński, Jakub Fichna
15 [GO] 2022―Sep―23 Correction: Oral antiviral treatments for COVID-19: opportunities and challenges Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, et al. (+8)
16 [GO] 2022―Sep―20 Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Yogendra Padwad, Vipin Hallan, Sanjay Kumar
17 [GO] 2022―Aug―24 Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance Robert Flisiak, Dorota Zarębska-Michaluk, Magdalena Rogalska, Justyna Anna Kryńska, Justyna Kowalska, Ewa Dutkiewicz, et al. (+7)
18 [GO] 2022―Aug―23 Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study Seyed Saman Talebi, Mehran Ghasemi, Maryam Etminani-Esfahani, Younes Mohammadi, Rasool Haddadi
19 [GO] 2022―Aug―23 The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic Martyna Majchrzak, Marcin Poręba
20 [GO] 2022―Aug―05 Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein Deisy Segura-Villalobos, Daniela Roa-Velázquez, Dan I. Zavala-Vargas, Jessica G. Filisola-Villaseñor, Jorge Ivan Castillo Arellano, Edgar Morales Ríos, et al. (+2)
21 [GO] 2022―Jul―25 Oral antiviral treatments for COVID-19: opportunities and challenges Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, et al. (+7)
22 [GO] 2022―Mar―23 To aspirate or not to aspirate? Considerations for the COVID-19 vaccines Piotr Rzymski, Andrzej Fal
23 [GO] 2022―Jan―15 A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2 Kasi Pandima Devi, Mahmoud Reza Pourkarim, Marijn Thijssen, Antoni Sureda, Maryam Khayatkashani, Cosmin Andrei Cismaru, et al. (+4)
24 [GO] 2021―Nov―27 Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial Negar Toroghi, Ladan Abbasian, Anahid Nourian, Effat Davoudi-Monfared, Hossein Khalili, Malihe Hasannezhad, et al. (+4)
25 [GO] 2021―Aug―30 COVID-19: potential therapeutics for pediatric patients Nour K. Younis, Rana O. Zareef, Ghina Fakhri, Fadi Bitar, Ali H. Eid, Mariam Arabi
26 [GO] 2021―Jul―06 The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis Krzysztof Marciniec, Artur Beberok, Stanisław Boryczka, Dorota Wrześniok
27 [GO] 2021―Jun―27 Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, Mehnaz Kamal, Talha Jawaid, Bapi Gorain, et al. (+2)
28 [GO] 2021―Jun―24 Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective Amr Sonousi, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim, Abdo A. Elfiky, Wael M. Elshemey
29 [GO] 2021―Jun―04 Use of glucocorticoids and azithromycin in the therapy of COVID-19 Miguel de Lemos Neto, Rafael Costa Vieira Alexandre, Rafaela Oliveira Gallart Morra, Juliana Aparecida Souza da Paz, Shana Priscila Coutinho Barroso, Angela Castro Resende, et al. (+2)
30 [GO] 2021―May―10 Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study Yamini Pathak, Amaresh Mishra, Gourav Choudhir, Anuj Kumar, Vishwas Tripathi
31 [GO] 2021―Apr―21 Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective Seyed Hootan Hamidi, Sandhya Kadamboor Veethil, Seyedeh Harir Hamidi
32 [GO] 2021―Apr―11 Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis Raymond Pranata, Ian Huang, Sherly Lawrensia, Joshua Henrina, Michael Anthonius Lim, Antonia Anna Lukito, et al. (+2)
33 [GO] 2021―Mar―29 The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis Chia Siang Kow, Hamid A. Merchant, Zia Ul Mustafa, Syed Shahzad Hasan
34 [GO] 2021―Mar―05 Perspectives on glucocorticoid treatment for COVID-19: a systematic review Leonardo P. Cordeiro, Eduarda O. N. N. Linhares, Fernanda G. O. Nogueira, Daniel Moreira-Silva, Daniel J. M. Medeiros-Lima
35 [GO] 2021―Feb―24 Evaluation of effects of chronic nasal steroid use on rhinological symptoms of COVID-19 with SNOT-22 questionnaire Akif İşlek, Mustafa Koray Balcı
36 [GO] 2021―Feb―20 In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis Hikmat Permana, Ian Huang, Aga Purwiga, Nuraini Yasmin Kusumawardhani, Teddy Arnold Sihite, Erwan Martanto, et al. (+2)
37 [GO] 2021―Feb―19 Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2 Albert Cortés-Borra, Gonzalo Emiliano Aranda-Abreu
38 [GO] 2021―Jan―03 Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes Harpinder Kaur, Nishant Shekhar, Saurabh Sharma, Phulen Sarma, Ajay Prakash, Bikash Medhi
39 [GO] 2021―Jan―03 SARS-CoV-2 therapeutics: how far do we stand from a remedy? Anurag Singh, Vandana Gupta
40 [GO] 2020―Nov―09 The effect of tocilizumab on cytokine release syndrome in COVID-19 patients Carmen de Cáceres, Rodrigo Martínez, Pablo Bachiller, Laura Marín, José Manuel García
41 [GO] 2020―Oct―28 Overview of the possible role of vitamin C in management of COVID-19 Anis Abobaker, Aboubaker Alzwi, Alsalheen Hamed A. Alraied
42 [GO] 2020―Oct―15 Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis Krzysztof Marciniec, Artur Beberok, Paweł Pęcak, Stanisław Boryczka, Dorota Wrześniok
43 [GO] 2020―Oct―10 Observational study of people infected with SARS-Cov-2, treated with amantadine Gonzalo Emiliano Aranda-Abreu, José D. Aranda-Martínez, Ramiro Araújo, María Elena Hernández-Aguilar, Deissy Herrera-Covarrubias, Fausto Rojas-Durán
44 [GO] 2020―Sep―05 Drug repurposing approach to fight COVID-19 Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar, Raj Kumar Singh
45 [GO] 2020―Aug―20 Pharmacological treatments of COVID-19 Adeleh Sahebnasagh, Razieh Avan, Fatemeh Saghafi, Mojataba Mojtahedzadeh, Afsaneh Sadremomtaz, Omid Arasteh, et al. (+8)
46 [GO] 2020―Jul―22 Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19 Moshe Rogosnitzky, Paul Okediji, Igor Koman
 [1] 

46 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec